BDBM103367 US8552202, Example 4

SMILES C[C@H]1CC[C@@H](CC1)[C@H](NC(=O)c1cccc(c1)-n1ccnc1)C(=O)N1C[C@H](Cl)[C@H]2OCC(=O)[C@@H]12

InChI Key InChIKey=AWBHNFADBGSDNV-YKHRXLODSA-N

Data  5 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 103367   

TargetCathepsin S(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  0.400nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi: >3.00E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCathepsin L2(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  3.20E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCathepsin B(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  4.00E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetProcathepsin L(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  4.50E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent